Halozyme Therapeutics
Trade Halozyme Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
With a market cap of 9.47B, Halozyme Therapeutics(HALO) trades at $79.05. The stock has a price-to-earnings ratio of 27.89.
As of 2026-07-23, Halozyme Therapeutics(HALO) stock has fluctuated between $76.82 and $79.48. The current price stands at $79.05, placing the stock +2.9% above today's low and -0.5% off the high.
The Halozyme Therapeutics(HALO)'s current trading volume is 205.98K, compared to an average daily volume of 1.59M.
During the past year, Halozyme Therapeutics(HALO) stock moved between $57.33 at its lowest and $82.26 at its peak.
During the past year, Halozyme Therapeutics(HALO) stock moved between $57.33 at its lowest and $82.26 at its peak.
HALO News
...
In July 2026, Halozyme Therapeutics announced a global collaboration and license agreement with Incyte to develop subcutaneous formulations of INCA033989, using...
Halozyme Therapeutics (HALO) drew fresh attention after signing a global partnership and licence agreement with Incyte to apply its Enhanze technology to subcut...
Analyst ratings
73%
of 11 ratingsMore HALO News
(RTTNews) - Biopharmaceutical company Halozyme Therapeutics, Inc. (HALO) announced Monday that it has entered into a global collaboration and license agreement...
Halozyme Therapeutics (HALO) announced that it has entered into a global collaboration and license agreement with Incyte (INCY) to evaluate additional subcutane...
Partner trial for Darzalex Faspro using Halozyme's ENHANZE technology reported significant survival benefits for multiple myeloma patients. Late stage study re...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.